Drug Patents owned by Dow Pharm

1. List of Altreno drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10653656 DOW PHARM Topical pharmaceutical compositions for treating skin conditions
Aug, 2038

(15 years from now)

US11324710 DOW PHARM Topical pharmaceutical compositions for treating skin conditions
Aug, 2038

(15 years from now)

Drugs and Companies using TRETINOIN ingredient

Market Authorisation Date: 23 August, 2018

Treatment: Topical treatment of acne vulgaris in patients 9 years of age and older

Dosage: LOTION;TOPICAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic